Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

An in-house ELISA method for quantification of circulating tissue factor

Tay, S.P., and Cheong, S.K., (2002) An in-house ELISA method for quantification of circulating tissue factor. Malaysian Journal of Pathology, 24 (1). pp. 45-51. ISSN 0126-8635

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
231Kb

Official URL: http://www.mjpath.org.my/past_issue/MJP2002.1/An%20in-house%20ELISA%20method%20for%20quantification%20of%20circulating%20tissue%20factor.pdf

Affiliations

Universiti Kebangsaan Malaysia, Malaysia, Faculty of Medicine, Dept. of Pathology

Abstract

Tissue Factor (TF) is a low molecular weight transmembrane glycoprotein that initiates the clotting protease cascade. It is considered to be the principal regulator of the extrinsic coagulation pathway, hemostasis and thrombosis, as well as inflammation and cellular immune response. An in-house two-step direct sandwich ELISA (enzyme-linked immunosorbent assay) for immunological quantification of plasma TF was successfully developed. The assay employed a monoclonal antibody against human TF (1:400 dilution; 1250 nglml) and peroxidase-conjugated anti-TF IgG(1:1000 dilution; 2000 ng/ml) as capture and detecting antibodies respectively, whilst tetramethylbenzidine/H202 were utilized as substrates. Titration curves of recombinant TF were linear within 10 to 4000 pglml, with a detection limit of 36.3 1 pglml. It demonstrated low intra- (2.50 - 9.23 CV%) and inter-assays (5.65 - 13.57 CV%) variability, as well as satisfactory analytical recovery (91.55 - 103.95%) and good parallelism. The assay developed was intended to be applied for measurement of plasma TF levels in patients with thrombotic disorders.

Item Type:Journal
Additional Information:The financial support under the IRPA grant No. 06-02-02-0067 from the Ministry of Science, Technology and Environment is gratefully acknowledged.
Keywords:Tissue Factor, enzyme-linked immunosorbent assay, thrombotic disorders
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:1823

1. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134(5): 1087-97.

2. McVey JH. Tissue factor pathway. Bailliere's Clin Haematol 1999; 12(3): 361-72.

3. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9(6): 2752-5.

4. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71(6): 1893-6.

5. Schecter AD, Giesen PLA, Taby 0 , Rosenfield CL, Rossikhina M, Fyfe BS et al. Tissue factor expression in human arterial smooth muscle cells. J Clin Invest 1997; lOO(9): 2276-85.

6. Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75(2): 281-9

.

7. Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72(1): 128-33.

8. Carson SD. Tissue factor-initiated blood coagulation. Prog Clin Pathol 1984; 9: 1-14.

9. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997; 78(1): 759-64.

10. Lwaleed BA, Bass PS, Chisholm M, Francis JL. Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury. J Clin Pathol 1997; SO(4): 336-40.

11. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3(5): 379-84.

12. Harlow E, Lane D. Antibodies: a laboratory manual. New York: Cold Spring Harbour Laboratory, 1988: 553-612.

13. Wild DG. The immunoassay handbook. New York: Stockton Press, 1994.

14. Albrecht S, Kotzsch M, Siegert G, Luther T, Grobmann H, Grober M et al. Detection of circulating tissue factor and factor V11 in a normal population. Thromb Haemost 1996; 75(5): 772-7.

15. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87(2): 343-7.

16. Price CP, Newman DJ. Principles and practice of immunoassay. 2nd ed. New York: Stockton Press, 1997.

17. Brock DJ, Barron L, van Heyningen V. Enzymelinked immunospecific assays for human alphafetoprotein using monoclonal antibodies. Clin Chim Acta 1982; 122(3): 353-8.

18. Kemeny DM, Challacombe SJ. ELISA and other solid phase immunoassays: theoretical and practical aspects. Chichester: John Wiley & Sons, 1989.

19. Crowther JR. ELISA: theory and practice. Totowa: Humana Press, 1995. 20. Beumer T, Stoffelen E, Smits J, Carpay W. Microplate washing: process description and improvements. J Immunol Methods 1992; 154(1):

77-87.

21. Reen DJ. Enzyme-linked immunosorbent assay (ELISA). In: Walker JM, eds: Basic protein and peptide protocols. Totowa: Humana Press, 1994:461-6.

22. Diamandis EP, Christopoulous TK. Immunoassay. San Diego: Academic Press, 1996.

Repository Staff Only: item control page